Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers

Digestive Diseases and Sciences

Volumn 53, Issue 6, 2008, Pages 1537-1543

  Ohtsuka, Takao ^a   Nakafusa, Yuji ^a   Sato, Seiji ^a   Kitajima, Yoshihiko ^a   Tanaka, Masayuki ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; False positive; Gastric cancer; Tumor marker

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 43049122121     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0046-4     Document Type: Article

References (24)

1. Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colon carcinoma by immunological tolerance and absorption techniques. J Exp Med 121:439-462
2. Koprowski H, Herlyn M, Steplewski Z, Sears HF (1981) Specific antigen in serum of patients with colon carcinoma. Science 212:53-55
3. Tamada R, Hiramoto Y, Tsujitani S, Nozuka T, Okamura T, Masuda H, Sugimachi K, Inokuchi K (1985) Serum CEA level facilitate detection of recurrences of cancer in patients after gastrectomy. Jpn J Surg 15:23-29
4. Hamazoe R, Maeta M, Matsui T, Shibata S, Shiota S, Kaibara N (1992) CA72-4 compared with carcinoembryonic antigen as a tumor marker for gastric cancer. Eur J Cancer 28A:1351-1354
5. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K (1996) Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 5:133-139
6. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, Sugimachi K (1996) Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of Stage II and III gastric cancer. Hepatogastroenterology 43:1281-1287
7. Holubec L Jr, Topolcan O, Pikner R, Pecen L, Vacclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J (2000) The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Anticancer Res 20:5237-5244
8. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T (2001) Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 32:41-44
9. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H (2003) Tumor Marker Committee: The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 6:142-145
10. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr (2006) ASCO: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313-5327
11. Nakamura N, Aoji O, Yoshikawa T, Mori K, Kajiyama S, Yoshihiro K, Kanatsuna T, Kondo M (1986) Elevated serum CA19-9 levels in poorly controlled diabetic patients. Jap J Med 25:278-280
12. Marechal F, Berthiot G, Deltour G (1988) Serum levels of CA-50, CA19-9, CA-125, CA15-3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res 8:677-680
13. Osswald BR, Klee FE, Wysocki S (1993) The relaiability of highly elevated CA19-9 levels. Dis Markers 11:275-278
14. Nomura F, Koyama A, Ishijima M, Takano S, Narita M, Nakai T (1998) Serum levels of five tumor markersw for lung cancer in patients with chronic renal failure. Oncol Rep 5:389-392
15. Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romaqnoli P, Testa E, Risso D, Lantieri PB, Antonucci A, Boccato M, Milone S, Testa R (2000) Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis. Int J Biol Markers 15:226-230
16. Klapdor R, Bahlo M, Babinski A (2003) Atypical courses of serum tumor markers-4 case reports. Anticancer Res 23:845-850
17. Ohtsuka T, Sato S, Kitajima Y, Tanaka M, Nakafusa Y, Miyazaki K: False positive findings for tumor markers after curative gastrectomy for gastric cancer. Dig Dis Sci (online publication, DOI 10.1007/s10620-007-9825-1)
18. Tobe T, Kouchi M, Tanimura H, Huang CH (1967) Hyperglycemia after gastrectomy as a prediabetic state. Clinical study of 100 postgastrectomy patients. Arch Surg 94:836-840
19. Sudo T, Ishiyama K, Takemoto M, Kawamura M, Umemura H, Shiraha S, Kuyama T, Suzuki T, Tobe T (1982) Pancreatic endocrine function after total gastrectomy and truncal vagotomy. Am J Surg 144:539-544
20. Shaffer EA (1982) The effect of vagotomy on gallbladder function and bile composition in man. Ann Surg 195:413-418
21. Moreaux J, Bougaran J (1993) Early gastric cancer. A 25-year surgical experience. Ann Surg 217:347-355
22. Kitano S, Shiraishi N, Uyama I,Sugihara K, Tanigawa N (2007) Japanese Laparoscopic Surgery Study Group: a multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 245:68-72
23. Watanabe K, Ogata S, Kawazoe S, Watanabe K, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K (2006) Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submuicosal dissection and conventional mucosal resection. Gastrointest Endosc 63:776-782
24. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK (2006) US Multi-Society Task Force on Colorectal Cancer; American Cancer Society: guidelines for colonoscopic surveillance after polypectomy: a consensus updated by the USMulti-Society Task Force on colorectal cancer and the American Cancer Society. Gastroenterology 130:1872-1885